Jennifer Mazzola

Learn More
In this multicentre, placebo-controlled, 16-week trial, the efficacy and safety of oxcarbazepine monotherapy in patients with neuropathic pain of diabetic origin was evaluated. Eligible patients had a 6-month to 5-year history of neuropathic pain symptoms of diabetic origin and a pain rating of > or =50 units on the visual analogue scale (VAS).(More)
OBJECTIVES To evaluate the efficacy and safety of oxcarbazepine (1200 mg/day) in patients with painful diabetic neuropathy in a multicentre, double-blind, placebo-controlled, 16-week study. METHODS A total of 141 patients were randomized to oxcarbazepine (1200 mg/day) (n = 71) or placebo (n = 70). The primary efficacy variable was the change in mean(More)
A descriptive comparison study was conducted to determine if there were any coagulation, immune, nutritional, or insertion-related differences between 64 adult hospitalized clients who experienced phlebitis after insertion of a peripherally inserted central catheter (PICC) compared with a matched group of 64 adult hospitalized clients who did not develop(More)
  • 1